ReDenimの業績|難病治療の研究は千葉大学

論文

  1. Ihara, F., Sakurai, D., Horinaka, A., Fujisawa, A., Makita, Y., Sakurai, T., Yamasaki, K., Kunii, N., Motohashi, S., Nakayama, T. and Okamoto, Y. : CD45RA-Foxp3high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma. Cancer Immunol Immunother. in press.
  2. Hosokawa, H., Tanaka, T., Endo, Y., Kato, M., Shinoda, K., Suzuki, A., Motohashi, S., Matsumoto, M., Nakayama, K. I. and Nakayama, T. : Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells. Nat Commun. 7:11289 (2016).
  3. Mise, N., Takami, M., Suzuki, A., Kamata, T., Harada, K., Hishiki, T., Saito, T., Terui, K., Mitsunaga, T., Nakata, M., Ikeuchi, T., Nakayama, T., Yoshida, H. and Motohashi, S. : Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant NKT cells. Cancer Sci. 107(3):233-41 (2016).
  4. Uchida, M., Suzuki, S., Suzuki, T. and Ishii, I. : p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs. Microvasc Res. 103:36-40 (2016).
  5. Hirahara, K. and Nakayama, T. : CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol. 28(4):163-71 (2016).
  6. Frigault, M. J., Lee, J., Basil, M., Carpenito, C., Motohashi, S., Scholler, J., Kawalekar, O. U., Guedan, S., McGettigan, S., Posey, A Jr., Ang, S., Cooper, L. J., Platt, J., Johnson, F. B., Paulos, C. M., Zhao, Y., Kalos, M., Milone, M. and June, C. H. : Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res. 3(4):356-367 (2015).
  7. Ishii, I. and Uchida, M. : Three-Dimensional “Honeycomb” Culture System that Helps to Maintain the Contractile Phenotype of Vascular Smooth Muscle Cells. Muscle Cell and Tissue”, book edited by Kunihiro Sakuma, ISBN 978-953-51-2156-5 (2015).
  8. Matsumoto, J., Ariyoshi, N., Sakakibara, M., Nakanishi, T., Okubo, Y., Shiina, N., Fujisaki, K., Nagashima, T., Nakanishi, Y., Tamai, I., Yamada, H., Takeda, H. and Ishii, I. : Organic anion transporting polypeptide 2B1 expression vcorrelates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells. Drug Metab Pharmacokinet. 30(2):133-41 (2015).
  9. Hirahara, K., Onodera, A., Villario, AV., Bonelli, M., Sciumè, G., Laurence, A., Sun, HW., Brooks, RS., Vahedi, G., Shih, HY., Gutierrez-Cruz, G., Iwata, S., Suzuki, R., Miami, Y., Okamoto, Y., Wakayama, T., Holland, S., Hunter, CA., Kanno, Y. and O’Shea, JJ. : Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity. Immunity. 42(5):877-89 (2015).
  10. Horinaka, A., Sakurai, D., Ihara, F., Makita, Y., Kunii, N., Motohashi, S., Nakayama, T. and Okamoto, Y. : Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer. Cancer Sci. 107(3):207-16 (2015).
  11. Miasma, S., Sato, Y., Katayama, K., et al. : Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 5(11):e009157 (2015).
  12. Katayama, K., Misawa, S., Sato, Y., et al. : Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open. 5(1):e007330 (2015).
  • OurMission
  • Membar
  • Reprot
  • Links